Current regulatory challenges and approaches in the registration of herbal drugs in Europe-Reference-Cited by-同舟云学术

Current regulatory challenges and approaches in the registration of herbal drugs in Europe

Published:2016-01-02 Issue:1 Volume:33 Page:9-24
ISSN:1060-1333
Container-title:Clinical Research and Regulatory Affairs
language:en
Short-container-title:Clinical Research and Regulatory Affairs

Author:

Verma Nitin

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10601333.2016.1130717

Reference48 articles.

1. Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet

2. Herbal Remedies

3. USFDA. Draft guidance for industry on botanical drug products. U. S. Department of Health and Human Services, Food and Drug Administration and Center of Drug Evaluation and Research; 2000. p 1–22.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Phytomolecules in Alliance with Nanotechnology to Surmount the Limitations of Current Treatment Options in the Management of Osteoarthritis;Mini-Reviews in Medicinal Chemistry;2023-05

2. Clinical, ethical, and regulatory issues of botanicals;Phytopharmaceuticals and Herbal Drugs;2023

3. Ayurvedic Knowledge Inspired Approach to Modern Drug Discovery;Chemistry, Biological Activities and Therapeutic Applications of Medicinal Plants in Ayurveda;2022-11-16

4. Exploration of facilitators and barriers to the regulatory frameworks of dietary and herbal supplements: a scoping review;Journal of Pharmaceutical Policy and Practice;2022-09-05

5. Revisiting traditional Chinese materia medica from European historical collections and perspective for current use;Journal of Traditional and Complementary Medicine;2021-11